Day: February 12, 2021

Smart Meter Market to Derive Growth from the Presence of Several Large Scale Companies Across the World

Written by Customer Service on February 12, 2021. Posted in Mergers And Acquisitions.

Pune, India, Feb. 12, 2021 (GLOBE NEWSWIRE) — The global smart meter market size is projected to reach USD 44.18 by the end of 2026. Recent technological advancements have emerged in favor of the market in the coming years. According to a report published by Fortune Business Insights, titled “Smart Meter Market Size, Share & Industry Analysis, By Type (Smart Electric Meter, Smart Gas Meter, Smart Water Meter) By Technology (Automatic Meter Reading {AMR} and Advanced Meter Infrastructure), By Application (Residential, Commercial and Industrial), and Regional Forecast, 2019-2026,” the market was worth USD 24.53 billion in 2018 and will exhibit a CAGR of 7.7% during the forecast period, 2019-2026.Request To Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/smart-meter-market-102666The emergence...

Speedy Expansion of Renewables Capacities in Emerging Economies to Benefit the Battery Energy Storage Market Growth

Written by Customer Service on February 12, 2021. Posted in Mergers And Acquisitions.

Pune, India, Feb. 12, 2021 (GLOBE NEWSWIRE) — The global battery energy storage market size is projected to reach USD 19.74 billion by 2027, exhibiting a CAGR of 20.4% during the forecast period. Improving access to electricity across the globe will be a prominent trend shaping the growth trajectory of this market, postulates Fortune Business Insights™ in its report, titled “Battery Energy Storage Market Size, Share & COVID-19 Impact Analysis, By Battery Type (Lithium-Ion Battery, Lead Acid Battery, Flow Battery, and Others), By Connectivity (Off-Grid and On-Grid), By Application (Residential, Non-Residential, Utility, and Others), By Ownership (Customer-Owned, Third-Party Owned, and Utility-Owned) and Regional Forecast, 2020-2027”. According to a 2019 report produced by the International Renewable Energy Agency (IRENA), the...

Brunel Q4 and FY 2020 results: Operational discipline delivers strong results

Written by Customer Service on February 12, 2021. Posted in Earnings Releases And Operating Results.

Amsterdam, 12 February 2021 – Brunel International N.V. (Brunel; BRNL), a global provider of flexible workforce solutions and expertise today announced its fourth quarter and full year 2020 results.EBIT increased substantially to EUR 9.8 million helped by continued strong cost control resulting in 21% cost reductionRevenue stable vs Q3-20, despite seasonality effects Key points full year 2020EBIT of EUR 28.8 million driven by 15% lower cost baseRevenue down 14% due to Covid-19 related impact on global demand for flexible workforce solutionsFree cash flow of EUR 68 million resulting in an increase of net cash to EUR 155 millionEarnings per share of EUR 0.31 with a proposed dividend of EUR 0.30 (pay-out: 99%) over the 2020 financial yearCapital markets day planned in H1 2021 as Brunel gears up for the next phase of development and growth...

FLOW TRADERS Q420 RESULTS

Written by Customer Service on February 12, 2021. Posted in Earnings Releases And Operating Results.

FLOW TRADERS Q420 RESULTSAmsterdam, the Netherlands – Flow Traders N.V. (Euronext: FLOW) announces its unaudited Q420 resultsHighlightsMarket ETP Value Traded increased by 0.4% quarter-on-quarter and increased 48% FY20 vs FY19Flow Traders ETP Value Traded increased 14% quarter-on-quarter and increased 50% FY20 vs FY19, outperforming the broader marketFlow Traders recorded NTI of €130.3m in Q420 reflecting higher activity levels and strategic reallocations by investors. This compares to NTI of €78.3m in Q320 and €46.1m in Q419. FY20 NTI was €933.4m vs €216.4m in FY19In line with previous commitments, a further €2.5m has been donated to the Flow Traders Foundation with total donations of €10.0m. No further donations are required for the FoundationTotal operating expenses of €39.8m incurred in Q420, which included €0.9m of COVID-19...

Heijmans: strong financial results in 2020

Written by Customer Service on February 12, 2021. Posted in Public Companies.

Highlights:Revenue and underlying EBITDA increase by 9%;Net result 2020 higher at € 40 million;Order book at € 1.9 billion;Balance sheet shows continued improvement: higher solvency ratio (28.8%), robust cash position;Dividend proposal € 0.73 per share (pay-out ratio 40%);Outlook 2021: slightly lower revenue, profit at least at same level.Ton Hillen, CEO Heijmans:“The year 2020 was overshadowed by the pandemic, but our people showed resilience. Thanks to adapted health and safety regulations, we were able to continue work on projects. This enabled us to improve our results despite Covid-19 and the persistent nitrogen problem. Heijmans did not make use of any government support measures in 2020, such as the NOW scheme or the possibility of deferring tax payments. I am proud of an excellent performance by our employees in a dynamic and...

Heijmans: sterke financiële resultaten in 2020

Written by Customer Service on February 12, 2021. Posted in Public Companies.

Kernpunten:Omzet en onderliggende EBITDA stijgen met 9%;Netto resultaat 2020 stijgt naar € 40 miljoen;Orderportefeuille blijft met € 1,9 miljard op niveau;Balans opnieuw verbeterd: hogere solvabiliteit (28,8%), robuuste kaspositie;Dividendvoorstel € 0,73 per aandeel (payout ratio 40%);Outlook 2021: licht lagere omzet, ten minste gelijkblijvende winst. Ton Hillen, Voorzitter Raad van Bestuur/CEO Heijmans:“Het jaar 2020 is overschaduwd door de pandemie, maar onze mensen toonden veel veerkracht. Dankzij de aangepaste veiligheids- en gezondheidsvoorschriften konden de werkzaamheden op projecten continueren. Dat stelde ons in staat om ondanks Covid-19 en aanhoudende stikstofproblematiek onze resultaten te verbeteren. Heijmans maakte in 2020 geen gebruik van steunmaatregelen van de overheid, zoals de NOW-regeling of mogelijkheid tot uitstel...

Intertrust reports Q4 and FY 2020 results

Written by Customer Service on February 12, 2021. Posted in Public Companies.

Amsterdam – 12 February 2021.Intertrust N.V. (“Intertrust” or “Company”) [Euronext: INTER], a global leader in providing tech-enabled corporate and fund solutions to clients operating and investing in international business, today publishes its results for the fourth quarter and full year ended 31 December 2020.

Basilea reports derazantinib/PD-L1 checkpoint inhibitor combination results from dose-finding part of FIDES-02 study in patients with solid tumors at ASCO GU symposium

Written by Customer Service on February 12, 2021. Posted in Public Companies.

Basel, Switzerland, February 12, 2021Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that data on the safety, tolerability and preliminary efficacy of the fibroblast growth factor receptor (FGFR) inhibitor derazantinib in combination with the PD-L1 checkpoint inhibitor atezolizumab, in patients with advanced solid tumors from the phase 1b dose-finding cohort in the FIDES-02 study, were presented at the virtual American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2021), held from February 11 to 13, 2021.1The derazantinib-atezolizumab combination was well tolerated and no dose-limiting toxicities were observed. The most commonly reported adverse events were fatigue/asthenia (weakness), nausea and diarrhea. The study demonstrated that derazantinib and atezolizumab can be safely combined at doses of 300 mg...

Basilea präsentiert auf ASCO GU Symposium Dosisfindungs-Ergebnisse für Derazantinib/PD-L1-Checkpoint-Inhibitor-Kombination aus FIDES-02-Studie für Patienten mit soliden Tumoren

Written by Customer Service on February 12, 2021. Posted in Public Companies.

Basel, 12. Februar 2021Basilea Pharmaceutica AG (SIX: BSLN) gab heute bekannt, dass auf dem Symposium für urogenitale Krebserkrankungen der American Society of Clinical Oncology (ASCO GU 2021) Daten zur Sicherheit und Verträglichkeit sowie vorläufige Daten zur Wirksamkeit des Fibroblasten-Wachstumsfaktor Rezeptor (FGFR) Inhibitors Derazantinib in Kombination mit dem PD-L1-Checkpoint-Inhibitor Atezolizumab bei Patienten mit fortgeschrittenen soliden Tumoren aus der Phase-1b-Dosisfindungskohorte der FIDES-02-Studie präsentiert wurden.1 Die Fachkonferenz findet als virtuelle Veranstaltung vom 11. bis 13. Februar 2021 statt.Die Derazantinib-Atezolizumab-Kombination war gut verträglich und es wurden keine dosislimitierenden Nebenwirkungen beobachtet. Häufigste unerwünschte Ereignisse waren Müdigkeit/Asthenie (Kraftlosigkeit), Übelkeit und...

Small Business Accountant Toronto Makes The Accounting Process Easier For Their Clients

Written by Customer Service on February 12, 2021. Posted in Public Companies.

Accounting is among the most complicated and time-consuming process for both individuals and companies. Small Business Accountant Toronto offers their services to make accounting easier for their clients. With their well-experienced and knowledgeable staff, small business owners can easily manage their taxes and other accounting procedures.They know that accounting is a serious process, that’s why they only provide the most comprehensive service for their customers. Cross border tax accountant Toronto provides the best service for handling cross border tax issues. Their service is open to individuals and small business owners. With that, businesses can save their time and effort in doing their accounting works. Small Business Accountant Toronto values the trust and support of their clients. They continue to develop the best solutions to...

Day: February 12, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals